3rd Quarter - Report

ALLERGAN USA, INC. for ALLERGAN USA, INC.

Firm
Client
Income
—
Expenses
$850,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax Policy including changes to corporate tax structure

Foreign entity interest: Allergan plc, as the indirect parent of Allergan USA, Inc., has an interest to the extent the tax code affects foreign operations.

LobbyistCovered position, as disclosed
BRENT J FISK —
ROBERT W. LIVELY New —
ASHLIE VAN METER —

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Telecommunications TEC

Junk Fax regulations and interpretations, and rule promulgations

LobbyistCovered position, as disclosed
BRENT J FISK —
ROBERT W. LIVELY —
ASHLIE VAN METER —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); SENATE

Copyright/Patent/Trademark CPT

Patent Reform Proposals; Patent Settlement Proposals.

LobbyistCovered position, as disclosed
BRENT J FISK —
ROBERT W. LIVELY New —
COLMAN BRENDAN RAGAN —
ASHLIE VAN METER —

Contacted: Patent & Trademark Office (PTO); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Medicare and Medicaid Provisions reimbursement; Agriculture, Rural Development, Food and Drug Administration Appropriations

LobbyistCovered position, as disclosed
BRENT J FISK —
ROBERT W. LIVELY New —
ASHLIE VAN METER —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Food & Drug Administration (FDA); SENATE

Medical/Disease Research/Clinical Labs MED

Drug safety and efficacy; bioequivalence.

LobbyistCovered position, as disclosed
BRENT J FISK —
ROBERT W. LIVELY —
ASHLIE VAN METER —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); SENATE

Pharmacy PHA

Drug Labeling Drug Importation Track and Trace

LobbyistCovered position, as disclosed
BRENT J FISK —
ROBERT W. LIVELY —
ASHLIE VAN METER —

Contacted: Patent & Trademark Office (PTO); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues

LobbyistCovered position, as disclosed
BRENT J FISK —
ROBERT W. LIVELY —
ASHLIE VAN METER —

Contacted: Food & Drug Administration (FDA); SENATE; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ALLERGAN PLC Ireland Ireland 100.0% —

Affiliated organisations

OrganisationLocation
ALLERGAN, INC. Parsippany, NJ, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.